Z-2574-2018 Class III Terminated

Recalled by Diamedix Corporation — Miami Lakes, FL

FDA device recall Z-2574-2018 was initiated by Diamedix Corporation on Jan 5, 2018 and is designated Class III. Reason for recall: Contains a gel-like contaminant that may affect product performance. The recall status is terminated (terminated Nov 5, 2019). Affected quantity: 147.

Recall details

Product Type
Devices
Report Date
Aug 8, 2018
Initiation Date
Jan 5, 2018
Termination Date
Nov 5, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
147

Product description

Diamedix Is-EBV-EA-D IgG Enzyme Immunoassay Test Kit for In Vitro Diagnostic Use Catalog No. 720-640

Reason for recall

Contains a gel-like contaminant that may affect product performance.

Distribution pattern

AZ, CA, FL, IL, IN, KY, MA, MI, MN, MO, NH, NJ, NY, OH, OK, PA, RI, TN, TX, and WI

Code information

Lot T0006 Exp. 05/31/2018

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2574-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Diamedix Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-2574-2018. Report a data issue: hello@regdatalab.com.